Edition:
United Kingdom

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.37USD
22 Jun 2018
Change (% chg)

$-0.05 (-2.07%)
Prev Close
$2.42
Open
$2.42
Day's High
$2.45
Day's Low
$2.36
Volume
997,258
Avg. Vol
437,292
52-wk High
$3.55
52-wk Low
$2.15

Chart for

About

PDL BioPharma, Inc. seeks to provide return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotechnology, pharmaceutical and medical device industries. The Company's segments include income generating assets and product sales. The income generating... (more)

Overall

Beta: 0.56
Market Cap(Mil.): $526.96
Shares Outstanding(Mil.): 154.08
Dividend: --
Yield (%): --

Financials

  PDLI.OQ Industry Sector
P/E (TTM): 7.56 82.81 32.74
EPS (TTM): 0.45 -- --
ROI: 6.94 2.00 14.38
ROE: 9.15 3.49 16.08

BRIEF-PDL Biopharma Reports Q1 GAAP Earnings Per Share $0.01

* PDL BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-PDL Biopharma Shareholder, Sevensaoi Capital, Comments On The Nomination Of Shlomo Yanai To PDL Board

* PDL BIOPHARMA SHAREHOLDER, SEVENSAOI CAPITAL, COMMENTS ON THE NOMINATION OF SHLOMO YANAI TO THE PDL BOARD OF DIRECTORS AND DELIVERS LETTER TO THE BOARD OUTLINING SIGNIFICANT CONCERNS

09 Apr 2018

BRIEF-PDL Biopharma Announces Q4 Revenue Of $68 Million

* PDL BIOPHARMA ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

08 Mar 2018

BRIEF-PDL Biopharma Terminates Interest In Pursuing Acquisition Of Neos

* PDL BIOPHARMA TERMINATES INTEREST IN PURSUING ACQUISITION OF NEOS

20 Feb 2018

Earnings vs. Estimates